| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/01/2007 | US20070048272 Methods of treating cancer using IL-21 |
| 03/01/2007 | US20070048271 Methos of treating cancer using IL-21 |
| 03/01/2007 | US20070048270 Methods of treating cancer using il-21 |
| 03/01/2007 | US20070048269 Methods of treating cancer using il-21 |
| 03/01/2007 | US20070048268 Methods of treating cancer using il-21 |
| 03/01/2007 | US20070048267 Methods of treating cancer using il-21 |
| 03/01/2007 | US20070048266 Methods of treating cancer using il-21 |
| 03/01/2007 | US20070048263 composition with a IL-21 protein at a concentration of about 10 mg/ml IL-21 protein in about 10 mM histidine, 4.7% mannitol at pH 5.3; using an E. coli expression system for the large scale production of IL-21 to a level of greater than 1 g/L in fed batch fermentation |
| 03/01/2007 | US20070048262 Methods for treating viral infection using il-28 and il-29 |
| 03/01/2007 | US20070048260 Cytokine zalpha11 ligand fusion proteins |
| 03/01/2007 | US20070048259 Cytokine zalpha11 ligand |
| 03/01/2007 | US20070048258 Use of human Zven proteins and polynucleotides |
| 03/01/2007 | US20070048257 Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammation |
| 03/01/2007 | US20070048256 Expression vector comprising nucleotide sequences coding cytokine protein for diagnosis, prevention and treatment of thymus disorders |
| 03/01/2007 | US20070048255 Method for treatment of demyelinating central nervous system disease |
| 03/01/2007 | US20070048236 Peptide-based conditioners and colorants for hair, skin, and nails |
| 03/01/2007 | US20070048223 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070048222 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070048218 Compositions and Methods for the Diagnosis and Treatment of Tumor |
| 03/01/2007 | US20070048217 F-18 peptides for pre targeted positron emission tomography imaging |
| 03/01/2007 | DE19960225B4 Kristallines, in der asymmetrischen Einheit mindestens eine an der Katalyse beteiligte (Sub)-Domaine eines humanen m-Calpains aufweisendes Polypeptid, Verfahren zur Identifizierung von Verbindungen unter dessen Verwendung, Verfahren zu dessen Kristallisation und Verfahren zur Darstellung einer 3-dimensionalen Struktur dieses Peptids Crystalline, in the asymmetric unit, at least one involved in catalysis (Sub) -Domaine a human m-calpain polypeptide having, methods for identifying compounds with its use, method of crystallization and method for displaying a 3-dimensional structure of this peptide |
| 03/01/2007 | DE102005041414A1 Glass sponge collagen obtained by gradually corroding glass sponge basal spicule in alkaline solution; dialyzing the obtained extract and subsequently lyophilizing, useful for the production of e.g. biological material and bullets |
| 03/01/2007 | DE102005040347A1 Verfahren und Mittel zur Anreicherung, Entfernung und zum Nachweis von Listerien Method and means for the enrichment, removal and detection of Listeria |
| 03/01/2007 | CA2620903A1 Ply-gbs mutant lysins |
| 03/01/2007 | CA2620361A1 Poly-beta-peptides from functionalized beta-lactam monomers and antibacterial compositions containing same |
| 03/01/2007 | CA2620228A1 Therapeutically active .alpha.-msh analogues |
| 03/01/2007 | CA2620125A1 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 03/01/2007 | CA2620047A1 Prion inactivation |
| 03/01/2007 | CA2619989A1 Regulation of heterologous recombinant protein expression in methylotrophic and methanotrophic bacteria |
| 03/01/2007 | CA2619943A1 Compositions and methods for producing apolipoprotein gene products in lactic acid bacteria |
| 02/28/2007 | EP1757941A1 Method for immunochemically assaying anti-hm1.24 antibody |
| 02/28/2007 | EP1757704A2 Methods for detecting mutations associated with hypertrophic cardiomyopathy |
| 02/28/2007 | EP1757701A1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 02/28/2007 | EP1757697A2 Group B streptococcus antigens |
| 02/28/2007 | EP1757696A2 Group B streptococcus proteins, and their use |
| 02/28/2007 | EP1757695A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757694A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757693A2 Nucleic acids showing difference in expression between hepatoblastoma and normal liver |
| 02/28/2007 | EP1757692A1 GENE ENCODING GUANINE NUCLEOTIDE EXCHANGE FACTOR BINDING TO RhoA |
| 02/28/2007 | EP1757691A1 Novel monkey gpr103 and monkey qrfp and method of evaluating compound by using gpr103 |
| 02/28/2007 | EP1757690A1 Gene encoding guanine nucleotide exchange factor and its gene product |
| 02/28/2007 | EP1757689A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/28/2007 | EP1757687A1 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector |
| 02/28/2007 | EP1757621A2 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/28/2007 | EP1757619A2 Osteoprotegerin in milk |
| 02/28/2007 | EP1757618A2 Angiogenesis-associated proteins, and nucleic acids encoding the same |
| 02/28/2007 | EP1757617A1 Ret Ligand (RetL) for stimulating neural and renal growth |
| 02/28/2007 | EP1757616A2 Semaphorin receptors |
| 02/28/2007 | EP1757615A1 Fusion protein for inhibiting cervical cancer |
| 02/28/2007 | EP1757614A1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 02/28/2007 | EP1757325A1 Use of botulinum toxin for treating myofascial pain |
| 02/28/2007 | EP1757311A2 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 02/28/2007 | EP1757295A1 Peripheral-Type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 02/28/2007 | EP1756740A1 Crystal structure of dipeptidyl peptidase iv (dpp-iv) and uses thereof |
| 02/28/2007 | EP1756584A2 Enriched pag-55 fraction and methods for early detection of pregnancy in ungulate animals |
| 02/28/2007 | EP1756575A2 Detection of methamphetamine group drugs |
| 02/28/2007 | EP1756318A2 Aptamer-toxin molecules and method for using same |
| 02/28/2007 | EP1756287A2 Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof |
| 02/28/2007 | EP1756286A2 Maize multidrug resistance-associated protein polynucleotides and methods of use |
| 02/28/2007 | EP1756283A1 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 02/28/2007 | EP1756279A1 Method for producing l-amino acids by means of recombinant coryneform bacteria with reduced activity asur regulators |
| 02/28/2007 | EP1756278A2 Method of improving t cell receptors |
| 02/28/2007 | EP1756270A2 Diagnosis and treatment of myeloid and lymphoid cell cancers |
| 02/28/2007 | EP1756166A1 Prostate cancer diagnosis and treatment |
| 02/28/2007 | EP1756160A2 Oligomeric peptides and their use for the treatment of hiv infections |
| 02/28/2007 | EP1756159A1 C1q family member proteins with altered immunogenicity |
| 02/28/2007 | EP1756158A1 Method for activating of t cell protein tyrosine phosphatase and therapeutical methods based thereon |
| 02/28/2007 | EP1756157A1 Gerbil neurokinin 1 receptor |
| 02/28/2007 | EP1756156A1 Selective vpac2 receptor peptide agonists |
| 02/28/2007 | EP1756155A2 PURIFIED INTERLEUKIN-15/Fc FUSION PROTEIN AND PREPARATION THEREOF |
| 02/28/2007 | EP1756154A2 EXPRESSION SYSTEM FOR PREPARING IL-15/Fc FUSION PROTEINS AND ITS USE |
| 02/28/2007 | EP1756153A2 Prokineticin 2beta peptide and its use |
| 02/28/2007 | EP1756152A2 Biologically active peptide vapeehptllteaplnpk derivatives |
| 02/28/2007 | EP1756151A1 Osteoblast growth factor |
| 02/28/2007 | EP1756150A2 Group 1 mite polypeptide variants |
| 02/28/2007 | EP1756149A1 Live, oral vaccine for protection against shigella dysenteriae serotype 1 |
| 02/28/2007 | EP1756148A2 Insecticidal toxin complex fusion proteins |
| 02/28/2007 | EP1756147A2 Peptides for inducing a ctl and/or htl response to hepatitis c virus |
| 02/28/2007 | EP1756146A2 Immunogenic domains of sars coronavirus |
| 02/28/2007 | EP1756145A1 Production of polypeptides by improved secretion |
| 02/28/2007 | EP1756144A2 Isolated nucleic acid molecules encoding a novel phosphoprotein-darpp-32, encoded protein and uses thereof |
| 02/28/2007 | EP1756143A1 Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same |
| 02/28/2007 | EP1756133A1 Therapeutic heparins and their binding to interleukins 4 and 5, and pecam-1 |
| 02/28/2007 | EP1755670A2 Methods for treating vascular disease |
| 02/28/2007 | EP1755669A2 Methods and compositions for specifically targeting human hepatocellular carcinoma cells |
| 02/28/2007 | EP1755667A2 Stable peptide mimetic of hiv gp41 fusion intermediate |
| 02/28/2007 | EP1755660A2 Method for enhancing or inhibiting insulin-like growth factor-i |
| 02/28/2007 | EP1755658A2 Human complement c3 derivates with cobra venom factor-like function |
| 02/28/2007 | EP1755653A2 Treatment methods utilizing albumin-binding proteins as targets |
| 02/28/2007 | EP1755645A2 Vegf inhibitors for the treatment of malignant pleural effusion |
| 02/28/2007 | EP1755644A2 Compositions comprising addl receptor syngap |
| 02/28/2007 | EP1755638A1 Multiple agent therapy for sexual dysfunction |
| 02/28/2007 | EP1755635A1 Treatment of inflammatory airway disease |
| 02/28/2007 | EP1755539A2 Flavivirus vaccines |
| 02/28/2007 | EP1633381A4 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity |
| 02/28/2007 | EP1578778A4 Ghrelin analogs |
| 02/28/2007 | EP1436002B1 Use of peptide vectors to improve the immune response to antigens |
| 02/28/2007 | EP1401493B1 Subunit vaccines and processes for the production thereof |
| 02/28/2007 | EP1390500A4 Transgenic non-human animals for pharmacological and toxicological studies |
| 02/28/2007 | EP1346041B1 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |